Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

Type your email in the box below to read this content NOW:

Interview

Guochuan Emil Tsai MD PhD MAS – Founder & CEO, SyneuRx, Taiwan

1With more than 100 peer-reviewed articles published and more than ten thousand citations, Guochuan Emil Tsai, founder and CEO of SyneuRx and Professor at the department of Psychiatry and Behavioral sciences at the University of California, Los Angeles (UCLA), is an internationally reputed scientist in neurosciences and brain disorders, whose main area of focus is the enhancement of the NMDA system. As CEO of SyneuRx, he provides an overview of the company’s extremely promising R&D pipeline and the seven groundbreaking CNS treatments that will undergo late stage trials in 2017; two of these products having already been granted breakthrough designations by the US FDA.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: